Currently, TGF-β has three well-known mechanisms accounting for tumor immune escape, including repressing the cytotoxicity of CD8+ T cells (49), promoting the conversion of CD4+CD25- T cells to T(reg) cells (50), and blocking T cells infiltration (51, 52). Here, TGFB1 is linked to neoplasm.